Information  X 
Enter a valid email address

ONCIMMUNE (ONC)

Date Time Source Announcement
29 Nov 2019 9:58 am
RNS
Results of Annual General Meeting
04 Nov 2019 2:46 pm
RNS
Notice of AGM and Posting of Annual Report
  7:00 am
RNS
Draw down of second tranche of credit facility
01 Nov 2019 7:10 am
RNS
Oncimmune and Biodesix seal deal
31 Oct 2019 7:00 am
RNS
Final Results
25 Oct 2019 7:00 am
RNS
Notice of Full Year Results ended May 2019
16 Oct 2019 5:01 pm
RNS
Oncimmune welcomes NHS review of cancer screenings
23 Sep 2019 7:00 am
RNS
Key appointments to further strengthen management
20 Sep 2019 2:32 pm
RNS
Appointment of Joint Broker
  7:00 am
RNS
EUR8.5m Credit Facility Secured
18 Sep 2019 7:00 am
RNS
Oncimmune to Present at 2019 CBIIC
09 Sep 2019 7:30 am
RNS
Positive Results for ECLS Trial Presentation
03 Sep 2019 12:00 pm
RNS
ECLS at 2019 World Conference for Lung Cancer
01 Aug 2019 12:00 pm
RNS
Solebury Trout European Biotech Investor Day
15 Jul 2019 7:00 am
RNS
Further Expansion in Spain for EarlyCDT Lung
04 Jul 2019 10:38 am
RNS
Commercialisation Partnership in Russia
02 Jul 2019 7:00 am
RNS
Proactive Investors One2One Investor Forum
28 Jun 2019 7:00 am
RNS
Commercialisation Agreement in US with Biodesix
26 Jun 2019 7:00 am
RNS
Business Update
04 Jun 2019 7:00 am
RNS
Positive Results for Early Cancer Detection Test
15 May 2019 7:00 am
RNS
Regulatory Approval in Israel for EarlyCDT?-Lung
10 May 2019 7:00 am
RNS
Initiation of a Multi-Centre Trial in China
17 Apr 2019 7:00 am
RNS
Holding(s) in Company
05 Apr 2019 7:00 am
RNS
Agreement for Portugal and Spain
02 Apr 2019 7:00 am
RNS
Appointment of Parag Mallick to Scientific Board
01 Apr 2019 5:19 pm
RNS
Holding(s) in Company
  7:00 am
RNS
EarlyCDT?-Lung Registered in Columbia
25 Mar 2019 7:00 am
RNS
Spanish Private Hospital to Sell EarlyCDT?-Lung
19 Mar 2019 7:00 am
RNS
Oncimmune acquires Protagen Diagnostics AG
13 Feb 2019 7:00 am
RNS
Half Year Results
31 Jan 2019 7:00 am
RNS
Notice of Half Year Results
24 Jan 2019 7:00 am
RNS
Grant of Options and PDMR notification
23 Jan 2019 7:00 am
RNS
Oncimmune to host Science Day in London today
14 Jan 2019 7:00 am
RNS
Oncimmune Science Day
20 Dec 2018 2:13 pm
RNS
Oncimmune signs US distribution agreement
13 Dec 2018 7:00 am
RNS
Oncimmune appoints new Scientific Board
06 Dec 2018 4:34 pm
RNS
Senior Leadership Team Appointments & Board Change
30 Nov 2018 10:46 am
RNS
Result of AGM
28 Nov 2018 7:10 am
RNS
Distribution Agreements & Registration Outside EU
05 Nov 2018 7:00 am
RNS
Annual Report and Accounts and AGM Notification
31 Oct 2018 7:00 am
RNS
Results for the year ended 31 May 2018
01 Oct 2018 7:00 am
RNS
Business Update
28 Sep 2018 7:00 am
RNS
Appointment of Non-Executive Director
25 Sep 2018 3:45 pm
RNS
IASLC World Conference on Lung Cancer Presentation
  7:00 am
RNS
Grant of options
24 Sep 2018 7:00 am
RNS
Board Change
13 Sep 2018 7:00 am
RNS
Appointment of Marco Casarin as General Manager
26 Jul 2018 12:33 pm
RNS
Notification & Public Disclosure of a Transaction
04 Jun 2018 7:38 am
RNS
Business Update
24 May 2018 7:00 am
RNS
New Distribution Agreements for EarlyCDT?-Lung Kit
23 May 2018 7:00 am
RNS
Oncimmune Publishes Study in PLOS ONE
14 May 2018 7:00 am
RNS
Oncimmune Launches EarlyCDT?-Liver Test in the US
23 Apr 2018 7:00 am
RNS
PDMR Notification
11 Apr 2018 2:01 pm
RNS
Holding(s) in Company
27 Mar 2018 8:00 am
RNS
Final tranche of �10m equity investment
  7:00 am
RNS
Appointment of Dr Adam Hill as CMO and CSO
13 Feb 2018 7:00 am
RNS
Interim Results for the half year ended 30 Nov 17
05 Feb 2018 7:01 am
RNS
University of Nottingham share sale
  7:00 am
RNS
Holdings in Company
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t